Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IACH MATH 2020 | Reduced-intensity conditioning regimens in ALL patients undergoing allo-HSCT

Zinaida Perić • 25 Jun 2020
IACH MATH 2020
Acute Lymphoblastic Leukemia Leukemia Busulfan Fludarabine Melphalan

Zinaida Perić, MD, PhD, University Hospital Centre Zagreb, School of Medicine, Zagreb, Croatia, discusses the retrospective study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT), which compared the three most popular reduced-intensity conditioning regimens in patients with acute lymphoblastic leukemia (ALL) undergoing allogeneic stem cell transplantation (allo-HSCT). This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Zinaida Perić

2:34
Advances in chronic GvHD management
Zinaida Perić • 28 Sep 2021
2:56
Ibrutinib, ruxolitinib & belumosudil for SR-cGvHD
Zinaida Perić • 28 Sep 2021
2:13
Next steps in chronic GvHD
Zinaida Perić • 28 Sep 2021
9:45
Management of chronic GvHD
Zinaida Perić • 25 Jun 2020

Related Videos

2:06
Managing relapsed ALL: the role of novel cellular therapies & importance of conditioning regimens
Christina Peters • 15 Apr 2024
1:14
Promising novel agents in AML: menin inhibitors
Mark Levis • 16 Apr 2024
3:02
EUPLAGIA-1: Phase I trial of GLPG5201, a CD19 CAR-T product, in R/R CLL and Richter's transformation
Valentin Ortiz-Maldonado • 16 Apr 2024
1:48
Do all patients require maintenance therapy following alloSCT?
Mark Levis • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals